Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2019
SIETES contiene 92806 citas

 
 
 1 a 17 de 17 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes. JAMA Intern Med 2018:13 de agosto. [Ref.ID 102824]
2. Cita con resumen
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru J-P, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D, on behalf of the Duration of Treatment for Spondylodiscitis (DTS) study group. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 2015;385:875-82. [Ref.ID 98935]
3. Cita con resumen
Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections. A systematic review of the literature. Arch Intern Med 2008;168:805-19. [Ref.ID 82768]
4. Cita con resumen
Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003;362:1828. [Ref.ID 68281]
5.
Kanellakopoulou K, Giamarellos-Bourboulis E J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000;59:1223-32. [Ref.ID 51191]
7. Cita con resumen
Javaloyas de Morlius M, Monreal Portella M. Tratamiento antibiótico por vía oral de la osteomielitis bacteriana del adulto: resultados tras dos años de seguimiento. Med Clin (Barc) 1999;113:488-9. [Ref.ID 47478]
8.
Bonazzi L, Gabbi E, Massari M. La prevenzione dell'endocardite batterica. Informazioni sui Farmaci 1999;23:12-6. [Ref.ID 44517]
9.
Tobin EH. Prosthetic joint infections: controversies and clues. Lancet 1999;353:770-1. [Ref.ID 43479]
10.
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE, for the Foreign-Body Infection (FBI) Study Group. Role of rifampicin for treatment of orthopedic implant-related staphyloccocal infections. A randomized controlled trial. JAMA 1998;279:1537-41. [Ref.ID 38408]
11.
Mader JT, Mohan D, Calhoun J. A practical guide to the diagnosis and management of bone and joint infections. Drugs 1997;54:253-64. [Ref.ID 33654]
12.
Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997;336:999-1007. [Ref.ID 31444]
13.
Balfour JA, Goa KL, (Technical editors). Proceedings of the 5th International Symposium on new quinolones. Drugs 1995;49:1-505. [Ref.ID 24809]
14.
Dirschl DR, Almekinders LC. Osteomyelitis. Common causes and treatment recommendations. Drugs 1993;45:29-43. [Ref.ID 19018]
15.
Gentry LO. Oral antimicrobial therapy for osteomyelitis. Ann Intern Med 1991;114:986-7. [Ref.ID 14902]
17. Cita con resumen
Vacek V, Hejzlar M, Slavik M, Pavlansky R. Penetration of clindamycin into bone in man. Preliminary report. Chemotherapy 1972;17:22-5. [Ref.ID 2105]
Seleccionar todas
 
 1 a 17 de 17